跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISINE FOR RED EYE WORKPLACE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VISINE FOR RED EYE WORKPLACE
Authorized
STANDARD
VISINE FOR RED EYE WORKPLACE
johnson & johnson inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
38f0e9c7bf673ccb
Company
johnson & johnson inc
Type
Standard
Approval Details
Approval Id
38f0e9c7bf673ccb
Drug Approval Canada Name
VISINE FOR RED EYE WORKPLACE
Product Name
VISINE FOR RED EYE WORKPLACE
Status
Cancelled Post Market
Status Date
2022-02-01
Original Market Date
2016-06-03
Din
02436086
Drug Class
Human
Dosage Form
Drops
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:32.00
Atc Original
S01GA52 TETRYZOLINE, COMBINATIONS
Atc Name
s 01 ga 52
Aig Number
0449769001
Company Name
johnson & johnson inc
Company Address
88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2
Active Ingredients
DEXTRAN 70
0.1 % / W/V
POLYETHYLENE GLYCOL 400
1 % / W/V
POVIDONE
1 % / W/V
TETRAHYDROZOLINE HYDROCHLORIDE
0.05 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
38f0e9c7bf673ccb
Type
Standard
Back to Health Canada Approvals